Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Maschmeyer

Showing results (21-30 of 97) with videos related to

Pageof 10
Sort By:
MMW Fortschritte Der Medizin|July 6, 2018
[Pulmonary infiltrates in haematological patients]Igor-Wolfgang Blau, Werner J Heinz, Stefan Schwartz, et al.
Annals of Hematology|September 19, 2003
Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Georg Maschmeyer, Thomas Beinert, Dieter Buchheidt, et al.
Infectious Disease Clinics of North America|May 20, 2003
Clinical pharmacology of antifungal compoundsAndreas H Groll, Juan C Gea-Banacloche, Axel Glasmacher, et al.
Leukemia|April 8, 2025
Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)Livio Pagano, Georg Maschmeyer, Frederic Lamoth, et al.
Leukemia & Lymphoma|July 20, 2011
Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II studyHaifa K Al-Ali, Nadja Jaekel, Christian Junghanss, et al.
Oncotargets and Therapy|July 10, 2013
Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemiaMichael Cross, Enrica Bach, Thao Tran, et al.
Leukemia|April 3, 2022
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
BMC Cancer|October 23, 2012
Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)Katrin Oertel, Karin Spiegel, Harald Schmalenberg, et al.
British Journal of Haematology|July 21, 2005
Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trialGernot Reich, Oliver A Cornely, Michael Sandherr, et al.
Cancer|December 15, 2005
Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patientsRobert Betts, Axel Glasmacher, Johan Maertens, et al.
Pageof 10

Showing results (21-30 of 97) with videos related to

Sort By:
Pageof 10
MMW Fortschritte Der Medizin|July 6, 2018
[Pulmonary infiltrates in haematological patients]Igor-Wolfgang Blau, Werner J Heinz, Stefan Schwartz, et al.
Annals of Hematology|September 19, 2003
Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Georg Maschmeyer, Thomas Beinert, Dieter Buchheidt, et al.
Infectious Disease Clinics of North America|May 20, 2003
Clinical pharmacology of antifungal compoundsAndreas H Groll, Juan C Gea-Banacloche, Axel Glasmacher, et al.
Leukemia|April 8, 2025
Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)Livio Pagano, Georg Maschmeyer, Frederic Lamoth, et al.
Leukemia & Lymphoma|July 20, 2011
Azacitidine in patients with acute myeloid leukemia medically unfit for or resistant to chemotherapy: a multicenter phase I/II studyHaifa K Al-Ali, Nadja Jaekel, Christian Junghanss, et al.
Oncotargets and Therapy|July 10, 2013
Pretreatment long interspersed element (LINE)-1 methylation levels, not early hypomethylation under treatment, predict hematological response to azacitidine in elderly patients with acute myeloid leukemiaMichael Cross, Enrica Bach, Thao Tran, et al.
Leukemia|April 3, 2022
Infectious complications of targeted drugs and biotherapies in acute leukemia. Clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the International Immunocompromised Host Society (ICHS) and the European Leukemia Net (ELN)Georg Maschmeyer, Lars Bullinger, Carolina Garcia-Vidal, et al.
BMC Cancer|October 23, 2012
Phase I trial of split-dose induction docetaxel, cisplatin, and 5-fluorouracil (TPF) chemotherapy followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1)Katrin Oertel, Karin Spiegel, Harald Schmalenberg, et al.
British Journal of Haematology|July 21, 2005
Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trialGernot Reich, Oliver A Cornely, Michael Sandherr, et al.
Cancer|December 15, 2005
Efficacy of caspofungin against invasive Candida or invasive Aspergillus infections in neutropenic patientsRobert Betts, Axel Glasmacher, Johan Maertens, et al.
Pageof 10